Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination

scientific article published on 25 August 2020

Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12935-020-01504-4
P932PMC publication ID7446116
P698PubMed publication ID32855620

P50authorCS ChimQ64761563
P2093author name stringGeorge A Calin
Dong-Yan Jin
Shaji Kumar
Wee-Joo Chng
Ming-Wai Poon
Kam-Leung Siu
Zhenhai Li
P2860cites workMonoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyQ24653006
Worms gang up on bacteriaQ27860588
CpG islands in vertebrate genomesQ27861045
Long non-coding RNAs in normal and malignant hematopoiesisQ28070169
Long non-coding RNAs: insights into functionsQ28131764
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working GroupQ28207984
Hypermethylation of gene promoters in hematological neoplasiaQ28216777
Epigenetic dysregulation of Wnt signaling pathway in multiple myelomaQ28249838
The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epitheliumQ28585080
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expressionQ29614326
Evolution and functions of long noncoding RNAsQ29614331
DNA methylation in health and diseaseQ30659938
International staging system for multiple myelomaQ34408882
Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.Q34413764
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaQ34450381
Structure, function and evolution of CpG island promotersQ35541032
Epigenomics: beyond CpG islands.Q35778671
Myeloma as a model for the process of metastasis: implications for therapyQ36079800
Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.Q36094729
Long non-coding RNAs and cancer: a new frontier of translational research?Q36208103
Epigenetic inactivation of the MIR129-2 in hematological malignancies.Q36621405
The Impact of DNA Methylation in Hematopoietic MalignanciesQ36724810
CpG island hypermethylation of tumor suppressor microRNAs in human cancerQ36854202
A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasisQ37064899
Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach.Q37343917
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.Q37400912
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathwayQ37424922
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and managementQ37623809
Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.Q37696142
Pathogenesis of myelomaQ37831905
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancerQ37921080
The genetic architecture of multiple myeloma.Q38001913
Interplay between the cancer genome and epigenomeQ38094260
SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathwayQ38344554
DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myelomaQ38595057
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaQ38832525
An Extended Least Squares Method for Aliasing-Resistant Vector Velocity EstimationQ39205060
LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myelomaQ41169814
Epigenetic inactivation of the MIR34B/C in multiple myeloma.Q43422429
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondQ47283493
Long Non-Coding RNAs in Multiple MyelomaQ48124218
Molecular detection of minimal residual disease in multiple myeloma.Q48371783
Epigenetic silencing of EVL/miR-342 in multiple myeloma.Q49838762
Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451.Q50853841
Epigenetic silencing of MIR203 in multiple myeloma.Q53285292
RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironment.Q54206324
Epigenetic silencing of LPP/miR-28 in multiple myeloma.Q55263293
Different prognostic values of p15(INK4b) and p16(INK4a) gene methylations in multiple myelomaQ73229221
DNA methylation changes in multiple myelomaQ80468799
P304page(s)403
P577publication date2020-08-25
P1433published inCancer Cell InternationalQ1829859
P1476titleEpigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination
P478volume20

Search more.